OTC Markets OTCPK - Delayed Quote USD

Nova Leap Health Corp. (NVLPF)

0.1950
+0.0094
+(5.06%)
At close: May 23 at 11:10:28 AM EDT
Loading Chart for NVLPF
  • Previous Close 0.1856
  • Open 0.1950
  • Bid --
  • Ask --
  • Day's Range 0.1950 - 0.1950
  • 52 Week Range 0.1475 - 0.3400
  • Volume 50,000
  • Avg. Volume 5,963
  • Market Cap (intraday) 17.707M
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 19.50
  • EPS (TTM) 0.0100
  • Earnings Date Aug 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, medication reminders, medication administration by nursing staff, and daily living activities. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

novaleaphealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NVLPF

View more

Performance Overview: NVLPF

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NVLPF
2.33%
S&P/TSX Composite index (^GSPTSE)
6.31%

1-Year Return

NVLPF
24.83%
S&P/TSX Composite index (^GSPTSE)
18.59%

3-Year Return

NVLPF
36.15%
S&P/TSX Composite index (^GSPTSE)
25.12%

5-Year Return

NVLPF
27.52%
S&P/TSX Composite index (^GSPTSE)
72.29%

Compare to: NVLPF

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: NVLPF

View more

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    17.65M

  • Enterprise Value

    19.65M

  • Trailing P/E

    19.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.64

  • Price/Book (mrq)

    0.94

  • Enterprise Value/Revenue

    0.74

  • Enterprise Value/EBITDA

    9.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.13%

  • Return on Assets (ttm)

    2.14%

  • Return on Equity (ttm)

    4.54%

  • Revenue (ttm)

    26.42M

  • Net Income Avi to Common (ttm)

    827.1k

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.33M

  • Total Debt/Equity (mrq)

    18.35%

  • Levered Free Cash Flow (ttm)

    1.3M

Research Analysis: NVLPF

View more

Company Insights: NVLPF

Research reports: NVLPF

View more

People Also Watch